Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphoglycerate mutase 1 pseudogene 11 (PGAM1P11) is a noncoding pseudogene related to the phosphoglycerate mutase 1 (PGAM1) gene. Unlike PGAM1, which encodes an enzyme central to glycolysis and is associated with cancer progression and targeted therapeutically[1][2][4], PGAM1P11 does not produce a functional protein and is not considered a therapeutic target. PGAM1P11 is annotated as a pseudogene in gene databases and serves as a genetic locus without known functional activity in human biology. If you are seeking information relevant to a drug target, you should refer to Phosphoglycerate mutase 1 (PGAM1), which is a glycolytic enzyme, metabolic regulator, and cancer therapy target[1][2][3][4]. PGAM1P11 does not have those attributes.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoglycerate mutase 1 pseudogene 11 (PGAM1P11).